Morbid Obesity Clinical Trial
Official title:
Effect of Boussignac Continuous Positive Airway Pressure Ventilation on PaO2 and PaO2/FiO2 Ratio Immediately After Extubation in Morbidly Obese Patients Undergoing Bariatric Surgery: a Randomized Controlled Trial
The purpose of this study is to determine if the application of Boussignac continuous positive airway pressure (CPAP) immediately after extubation improves PaO2 and PaO2/FiO2 ratio in morbidly obese patients undergoing gastric bypass surgery .
Background: In 2010, the prevalence of obesity in individuals above 15 years old in Portugal
was 15.5% for males and 17.7% for females. .In this country bariatric surgery has increased
significantly playing an important role in the treatment of individuals with BMI ≥ 40 kg/m2
or less than 35 kg/m2 in the presence of comorbidities.
Morbid obesity has a negative impact in the respiratory physiology and is associated with a
decreased compliance of the lung and chest wall, increased airway resistance, decreased
respiratory muscle strength, increased work of breathing, worsening of ventilation /
perfusion ratio and postoperative hypoxemia. General anesthesia and surgery in these
patients will maximize these physiologic alterations.
Ahmad et al. (2008) found that morbid obesity per se, regardless of the presence of
obstructive sleep apnea was associated with increased risk of desaturation in the first 24h
of the postoperative period.
Gaszynski et al. (2007) found that the use of Boussignac CPAP in the postoperative period of
patients undergoing bariatric surgery improved oxygenation. However, it was used capillary
blood gas analysis not arterial blood and the FiO2 was different between groups.
More recently, in 2011, Wong et al. investigated the effect of Boussignac CPAP versus
Venturi mask in the first one hour after bariatric surgery, measuring the PaO2 / FiO2 ratio
at 1 hour and 2 hours of the postoperative period. The group maintained with CPAP showed
better results. There were no differences between the two groups for FEV1 and FVC. The study
does not reveal, however, the analgesic protocol used postoperatively or the patient's
position during the spirometric measurements. These variables could be possible confounders.
The PaO2 absolute value was not evaluated because of the different FiO2 between patients.
Objectives: We aim to assess the impact of the application of Boussignac CPAP ventilation
immediately after extubation for improving PaO2 and PaO2/FiO2 ratio in morbidly obese
patients submitted to gastric bypass surgery. As a secondary objective we intend to evaluate
if there are differences in spirometry parameters.
Methods: A randomized controlled study on 24 patients undergoing gastric bypass surgery.
Control group receives a Ventury mask immediately after extubation and the intervention
group gets the Boussignac CPAP immediately after extubation. Both groups have the same
anesthetic protocol during the intraoperative period and receive a 50% FiO2 after
extubation. Venturi mask and Boussignac CPAP are maintained for two hours. A blood sample is
collected from radial artery to measure PaO2 and calculate PaO2/FiO2 ratio before surgery
and at 1, 2 and 24 hours after extubation in both groups. Evaluation of forced expiraroty
volume in 1 second (FEV1) and forced vital capacity (FVC) with a portable spirometer is also
performed at the same intervals. Patients are monitored for oxygen saturation, arterial
pressure and cardiac rhythm while using the devices. Tolerance to the device, analgesic
requirements and sedation level are also monitored and registered.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03657927 -
A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients
|
N/A | |
Recruiting |
NCT04934826 -
Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass
|
N/A | |
Completed |
NCT03181347 -
The Microbiology of Bariatric Surgery
|
N/A | |
Completed |
NCT03886870 -
Obesity, Lifestyle and Work Intervention
|
N/A | |
Active, not recruiting |
NCT04433338 -
The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery
|
N/A | |
Completed |
NCT03553849 -
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
|
N/A | |
Completed |
NCT05854875 -
Diabetes Remission After RYGBP and RYGBP With Fundus Resection
|
N/A | |
Not yet recruiting |
NCT03203161 -
Registry on Obesity Surgery in Adolescents
|
||
Not yet recruiting |
NCT03601273 -
Bariatric Embolization Trial for the Obese Nonsurgical
|
Phase 1 | |
Recruiting |
NCT02129296 -
Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01564732 -
Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
|
N/A | |
Completed |
NCT02033265 -
Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
|
||
Not yet recruiting |
NCT01652105 -
Randomized Trial of Preoperative Diets Before Bariatric Surgery
|
N/A | |
Completed |
NCT01963637 -
Gastric Volumetry by Gastric Tomodensitometry With Gas
|
N/A | |
Terminated |
NCT01759550 -
Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
|
||
Completed |
NCT01955993 -
Fentanyl Metabolism in Obese Adolescents
|
N/A | |
Completed |
NCT01149512 -
Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program
|
N/A | |
Recruiting |
NCT01685177 -
Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient
|
N/A | |
Terminated |
NCT01041261 -
Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery
|
N/A | |
Completed |
NCT00624624 -
Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism
|
N/A |